Breaking News
Investing Pro 0
🙌 It's Here: the Only Stock Screener You'll Ever Need Get Started

10 Best And Worst Performing Small-Cap Stocks In July 2022

By ValueWalkStock MarketsAug 23, 2022 01:21AM ET
www.investing.com/analysis/10-best-and-worst-performing-smallcap-stocks-in-july-2022-200628860
10 Best And Worst Performing Small-Cap Stocks In July 2022
By ValueWalk   |  Aug 23, 2022 01:21AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US2000
+1.74%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DOV
+2.46%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TGT
+0.14%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SAVA
+2.80%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ATRA
-1.67%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SRG
+1.88%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

The small-cap Russell 2000 gained over 10% in July, compared to a jump of 9.1% for the S&P 500. It is the biggest percentage-point outperformance since February this year. Despite the July rebound, the Russell 2000 has dropped by around 16% this year, compared to an over 13% drop for the S&P 500. Amid such a backdrop, let’s look at the ten best and worst performing small-cap stocks in July 2022.

5 Best Performing Small-Cap Stocks In July 2022

We have taken the July return data of the small-cap stocks (from finviz.com) to come up with the ten best and worst performing small-cap stocks in July 2022.

5. Seritage Growth Properties (129%)

Founded in 2015 and headquartered in New York City, Seritage Growth Properties (NYSE:SRG) is a real estate investment trust (REIT) that deals in retail properties throughout the United States. Its shares are up by almost 1% year-to-date and up almost 66% in the last three months. As of this writing, the shares are trading at over $13 (52-week range of $4.90 to $17.12), giving it a market capitalization of more than $900 million.

4. Velo3D (136%)

Founded in 2014 and headquartered in Campbell, Calif, Velo3D (NYSE:VLD) company develops and makes metal laser sintering printing machines for 3D printing. Its shares are down by almost 45% year-to-date but are up by almost 76% in the last three months. As of this writing, the shares are trading at over $4.10 (52-week range of $1.2800 to $13.1800), giving it a market capitalization of more than $750 million.

3. Target Hospitality (145%)

Founded in 1978 and headquartered in The Woodlands, Texas, Target Hospitality (NASDAQ:TH) offers rental accommodations with premium catering and value-added hospitality services. Its shares are up by over 298% year-to-date and up over 138% in the last three months. As of this writing, the shares are trading at over $13 (52-week range of $2.72 to $14.86), giving it a market capitalization of more than $1.30 billion.

2. Rhythm Pharmaceuticals (195%)

Founded in 2008 and headquartered in Boston, Rhythm Pharmaceuticals (NASDAQ:RYTM) is a biopharmaceutical company that develops and commercializes peptide therapeutics for treating gastrointestinal diseases and genetic deficiencies. Its shares are up by almost 150% year-to-date and up over 600% in the last three months. As of this writing, the shares are trading at over $24 (52-week range of $3.04 to $27.29), giving it a market capitalization of more than $1.20 billion.

1. Rex American Resources (238%)

Founded in 1984 and headquartered in Dayton, Ohio, REX American Resources (NYSE:REX) invests in alternative energy and ethanol production entities. Its shares are up by almost 1% year-to-date and up over 9% in the last three months. As of this writing, the shares are trading at over $32 (52-week range of $24.02 to $37.81), giving it a market capitalization of more than $550 million.

5 Worst Performing Small-Cap Stocks In July 2022

5. Cardlytics (-40%)

Founded in 2008 and headquartered in Atlanta, Cardlytics (NASDAQ:CDLX) develops marketing solutions through its purchase intelligence platform. Its shares are down by over 76% year-to-date and down almost 46% in the last three months. As of this writing, the shares are trading at over $15 (52-week range of $11.96 to $99.47), giving it a market capitalization of more than $500 million.

4. Cassava Sciences (-45%)

Founded in 1998 and headquartered in Austin, Texas, Cassava Sciences (NASDAQ:SAVA) develops novel drugs and diagnostics with a focus on the treatment of Alzheimer’s disease. Its shares are down by over 41% year-to-date and down over 6% in the last three months. As of this writing, the shares are trading at over $24 (52-week range of $13.84 to $123.37), giving it a market capitalization of more than $1 billion.

3. Forge Global Holdings (-50%)

Founded in 2014 and headquartered in San Francisco, Forge Global (NYSE:FRGE) is a financial services platform that serves unique needs of the private markets. Its shares are down by over 63% year-to-date and down almost 83% in the last three months. As of this writing, the shares are trading at over $3.60 (52-week range of $3.63 to $47.50), giving it a market capitalization of more than $620 million.

2. Energy Vault Holdings (-55%)

Founded in 2017 and headquartered in Dover, Del., Energy Vault (NYSE:NRGV) develops sustainable energy storage solutions to transform the approach toward utility-scale energy storage for grid resiliency. Its shares are down by almost 47% year-to-date and down over 58% in the last three months. As of this writing, the shares are trading at over $5.00 (52-week range of $3.97 to $22.10), giving it a market capitalization of more than $700 million.

1. Atara Biotherapeutics (-60%)

Founded in 2012 and headquartered in South San Francisco, Calif., Atara Biotherapeutics (NASDAQ:ATRA) is an allogeneic T-cell immunotherapy company that develops transformative therapies for patients with serious diseases. Its shares are down by almost 72% year-to-date and down almost 11% in the last three months. As of this writing, the shares are trading at over $4.30 (52-week range of $2.83 to $20.04), giving it a market capitalization of more than $400 million.

10 Best And Worst Performing Small-Cap Stocks In July 2022
 

Related Articles

10 Best And Worst Performing Small-Cap Stocks In July 2022

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email